PUBLISHER'S NOTE. First in Line on Catalent's Line.
| Publicado en: | BioPharm International Vol. 37; no. 3; p. 6 |
|---|---|
| Autor principal: | |
| Formato: | editorial Journal Article |
| Publicado: |
MJH Life Sciences
Mar2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=176164780&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 176164780 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Mar2024 vid: 37 iid: 3 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 176164780 176164780 176164780 176164780 ppf: 6 ppct: 0 formats: fmt: @attributes: type: P tig: atl: PUBLISHER'S NOTE. First in Line on Catalent's Line. aug: au: Hennessy Jr, Mike sug: subj: Pharmaceutical Companies Mergers and Acquisitions Healthcare Supply Chain United States Food and Drug Administration Medication Shortage pubtype: Trade Publication doctype: editorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|